Financial giants have made a conspicuous bullish move on ResMed. Our analysis of options history for ResMed RMD revealed 10 unusual trades.
Delving into the details, we found 70% of traders were bullish, while 20% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $195,625, and 6 were calls, valued at $457,915.
Projected Price Targets
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $180.0 and $210.0 for ResMed, spanning the last three months.
Volume & Open Interest Development
In terms of liquidity and interest, the mean open interest for ResMed options trades today is 396.78 with a total volume of 384.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for ResMed's big money trades within a strike price range of $180.0 to $210.0 over the last 30 days.
ResMed Call and Put Volume: 30-Day Overview
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RMD | CALL | SWEEP | BULLISH | 10/18/24 | $13.9 | $13.1 | $13.5 | $195.00 | $198.4K | 55 | 13 |
| RMD | CALL | SWEEP | BULLISH | 08/16/24 | $10.1 | $9.2 | $9.7 | $195.00 | $93.1K | 236 | 24 |
| RMD | PUT | SWEEP | NEUTRAL | 10/18/24 | $8.9 | $8.7 | $8.7 | $185.00 | $84.0K | 477 | 1 |
| RMD | CALL | SWEEP | BULLISH | 08/16/24 | $12.4 | $11.9 | $12.4 | $190.00 | $62.0K | 332 | 16 |
| RMD | CALL | SWEEP | BULLISH | 10/18/24 | $11.5 | $11.5 | $11.5 | $200.00 | $50.2K | 454 | 25 |
About ResMed
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
After a thorough review of the options trading surrounding ResMed, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
Current Position of ResMed
- With a volume of 166,706, the price of RMD is up 2.32% at $193.79.
- RSI indicators hint that the underlying stock may be approaching oversold.
- Next earnings are expected to be released in 27 days.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest ResMed options trades with real-time alerts from Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date of Trade | ticker | Put/Call | Strike Price | DTE | Sentiment |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
